NDC 17478-172

Xopenex

Levalbuterol Hydrochloride

Xopenex is a Respiratory (inhalation) Solution in the Human Prescription Drug category. It is labeled and distributed by Akorn. The primary component is Levalbuterol Hydrochloride.

Product ID17478-172_1d4b8d31-acf9-4345-9794-ee040fd63231
NDC17478-172
Product TypeHuman Prescription Drug
Proprietary NameXopenex
Generic NameLevalbuterol Hydrochloride
Dosage FormSolution
Route of AdministrationRESPIRATORY (INHALATION)
Marketing Start Date2015-02-27
Marketing CategoryNDA / NDA
Application NumberNDA020837
Labeler NameAkorn
Substance NameLEVALBUTEROL HYDROCHLORIDE
Active Ingredient Strength0 mg/3mL
Pharm ClassesAdrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 17478-172-24

2 POUCH in 1 CARTON (17478-172-24) > 12 VIAL, SINGLE-DOSE in 1 POUCH (17478-172-12) > 3 mL in 1 VIAL, SINGLE-DOSE
Marketing Start Date2015-02-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 17478-172-24 [17478017224]

Xopenex SOLUTION
Marketing CategoryNDA
Application NumberNDA020837
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2015-02-27

NDC 17478-172-12 [17478017212]

Xopenex SOLUTION
Marketing CategoryNDA
Application NumberNDA020837
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2015-02-27

Drug Details

Active Ingredients

IngredientStrength
LEVALBUTEROL HYDROCHLORIDE.31 mg/3mL

OpenFDA Data

SPL SET ID:7e2644e6-36c5-4988-8e52-bec90e2cd2f0
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 349590
  • 242754
  • 261136
  • 833470
  • 311286
  • 352132
  • UPC Code
  • 0317478173120
  • 0317478172123
  • 0317478174127
  • Pharmacological Class

    • Adrenergic beta2-Agonists [MoA]
    • beta2-Adrenergic Agonist [EPC]
    • Adrenergic beta2-Agonists [MoA]
    • beta2-Adrenergic Agonist [EPC]

    NDC Crossover Matching brand name "Xopenex" or generic name "Levalbuterol Hydrochloride"

    NDCBrand NameGeneric Name
    17478-171XopenexLevalbuterol Hydrochloride
    17478-172XopenexLevalbuterol Hydrochloride
    17478-173XopenexLevalbuterol Hydrochloride
    17478-174XopenexLevalbuterol Hydrochloride
    21695-153Xopenexlevalbuterol hydrochloride
    70518-1227XopenexXopenex
    0115-9930LevalbuterolLevalbuterol Hydrochloride
    0115-9931LevalbuterolLevalbuterol Hydrochloride
    0115-9932LevalbuterolLevalbuterol Hydrochloride
    35573-443LevalbuterolLevalbuterol Hydrochloride
    35573-444LevalbuterolLevalbuterol Hydrochloride
    35573-445LevalbuterolLevalbuterol Hydrochloride
    66993-021Levalbuterol HydrochlorideLevalbuterol Hydrochloride
    66993-022Levalbuterol HydrochlorideLevalbuterol Hydrochloride
    66993-023Levalbuterol HydrochlorideLevalbuterol Hydrochloride

    Trademark Results [Xopenex]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    XOPENEX
    XOPENEX
    77138209 3655211 Live/Registered
    SUNOVION PHARMACEUTICALS INC.
    2007-03-22
    XOPENEX
    XOPENEX
    77138201 3651698 Live/Registered
    SUNOVION PHARMACEUTICALS INC.
    2007-03-22
    XOPENEX
    XOPENEX
    75468045 2350721 Live/Registered
    SUNOVION PHARMACEUTICALS INC.
    1998-04-14

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.